Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of K-115 added to latanoprost in POAG and ocular hypertension
jRCT2080221658Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing K-115 add-on to latanoprost with Placebo add-on to latanoprost (2 arms).
02
Drugs
ripasudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCT2080221658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221658.